Immunotherapy Slows Progression of Chronic Lymphocytic LeukemiaSpecialty Pharmacy TimesA new immunotherapeutic strategy using 2 checkpoint inhibitors blocked the development of chronic lymphocytic leukemia (CLL) in preclinical stages and could serve as… Continue reading
Immunotherapy Slows Progression of Chronic Lymphocytic LeukemiaSpecialty Pharmacy TimesA new immunotherapeutic strategy using 2 checkpoint inhibitors blocked the development of chronic lymphocytic leukemia (CLL) in preclinical stages and could serve as… Continue reading
Gene TherapySickle Cell Anemia NewsGene therapy is an experimental technique that aims to treat genetic diseases by altering a disease-causing gene or introducing a healthy copy of a mutated gene to the body. The U.S. Food and Drug Administration appro… Continue reading
BioPharma-Reporter.com |
Roche’s immunotherapy combo receives FDA priority review
BioPharma-Reporter.com Roche’s immunotherapy combination has received priority review after Phase III trial results showed potential to provide significant survival benefit in the initial treatment of NSCLC. The US Food and Drug Administration (FDA) has granted Roche … |
MD Magazine |
Hossein Ameri, MD: Will CRISPR Fix Retinitis Pigmentosa?
MD Magazine Thomas Castles. @Thomas_Castles. Currently, patients with retinitis pigmentosa (RP) are limited to receiving retinal prosthesis. It’s the only approved treatment for the condition, and is only suitable for patients with advanced disease and profound … |
|
Protagen Collaborating With UCSF on Prostate Cancer Immunotherapy Work
360Dx NEW YORK (360Dx) – Protagen said today it has entered a collaboration with the University of California, San Francisco to use the company’s SeroTag platform for research into immunotherapies for prostate cancer. The collaboration will use Protagen’s … Protagen AG Collaborates with UCSF to Study Better Immuno-Profiling of Cancer Patients Receiving ImmunotherapyFort Bend Herald |